Grau C, Jakobsen M H, Harbo G, Svane-Knudsen V, Wedervang K, Larsen S K, Rytter C
Department of Oncology, Aarhus University Hospital, Denmark.
Acta Oncol. 2001;40(1):19-23. doi: 10.1080/028418601750070993.
Cancer of the nasal cavity and paranasal sinuses is a rare disease. The many different histologies and sites make the management of this disease a challenge. The current report from the Danish Society for Head and Neck Oncology comprises a joint analysis of five retrospective series covering the entire country, with 315 patients seen in the 10-year period from 1 January 1982 to 31 December 1991. Tumour sites were nasal cavity (n = 156), maxillary sinus (n = 139), ethmoid sinus (n = 14), sphenoid sinus (n = 5) and frontal sinus (one case). The most common histologies included squamous cell carcinoma (126 cases), adenocarcinoma (41 cases), malignant melanoma (38 cases) and malignant lymphoma (34 cases). A total of 284 patients (90%) received treatment with curative intent; most of these patients were treated with radiotherapy, either alone (120 patients) or in combination with surgery (111 patients). There was no significant difference between the five centres in disease specific survival and overall survival. The results showed that histology, localization and nodal involvement were significant prognostic factors for locoregional control and survival. Patients with squamous cell carcinoma had a significantly poorer prognosis compared with patients with adenocarcinoma. However, a Cox multivariate analysis revealed that this was likely the result of tumour localization, as most adenocarcinomas were in the nasal cavity. The experience from this data collection has inspired the Danish Society for Head and Neck Oncology to arrange common data registration of several other clinical head and neck series. In the future, the Society plans to expand this activity further.
鼻腔和鼻窦癌是一种罕见疾病。其众多不同的组织学类型和发病部位使得该疾病的治疗成为一项挑战。丹麦头颈肿瘤学会的这份最新报告对涵盖全国的五个回顾性系列进行了联合分析,在1982年1月1日至1991年12月31日的10年期间共诊治了315例患者。肿瘤发病部位为鼻腔(n = 156)、上颌窦(n = 139)、筛窦(n = 14)、蝶窦(n = 5)和额窦(1例)。最常见的组织学类型包括鳞状细胞癌(126例)、腺癌(41例)、恶性黑色素瘤(38例)和恶性淋巴瘤(34例)。共有284例患者(90%)接受了根治性治疗;其中大多数患者接受了放疗,单独放疗(120例患者)或放疗联合手术(111例患者)。五个中心在疾病特异性生存率和总生存率方面无显著差异。结果显示,组织学类型、肿瘤定位和淋巴结受累情况是局部区域控制和生存的重要预后因素。与腺癌患者相比,鳞状细胞癌患者的预后明显较差。然而,Cox多因素分析显示,这可能是肿瘤定位的结果,因为大多数腺癌位于鼻腔。此次数据收集的经验促使丹麦头颈肿瘤学会对其他几个临床头颈系列进行共同数据登记。未来,该学会计划进一步扩大这项活动。